Ypsilon Therapeutics is a biotechnology research company founded in 2024 and headquartered in Waltham, Massachusetts, that develops T cell receptor mimics against tumor antigens.
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Ypsilon Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Ypsilon Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.